Article

New Scholarship Announced for Underrepresented Racial and Ethnic Groups

Author(s):

The American Academy of Psychiatry and the Law scholarship aims to foster a welcoming and supportive environment for forensic psychiatrists of color.

freshidea_AdobeStock

freshidea_AdobeStock

The American Academy of Psychiatry and the Law (AAPL) has created a scholarship for forensic psychiatrists from underrepresented racial and ethnic groups in honor of Charles Dike, FRCPsych, MBChB, MPH.

The purpose of the AAPL Charles Dike Scholarship is to support forensic psychiatrists within AAPL who belong to underrepresented racial and ethnic groups, and to increase and maintain active AAPL membership among forensic psychiatrists of color—particularly those who are early-career—by fostering a supportive and welcoming environment. In order to be eligible, applicants must have completed a forensic fellowship, be current and active AAPL members, and have contributed to the forensic psychiatry field.1

Charles Dike, FRCPsych, MBChB, MPH

Charles Dike, FRCPsych, MBChB, MPH

AAPL named the scholarship for Dike to honor his longtime membership and service to AAPL. Dike is an associate professor of psychiatry and co-director of the Law and Psychiatry Division of the Yale University Department of Psychiatry, as well as medical director of the Connecticut Department of Mental Health and Addiction Services. He has served AAPL in a variety of capacities over the years, holding leadership positions within the AAPL Executive Council, the Ethics Committee, the Forensic Hospital Services Committee, and the Diversity Committee. He has also served as editor of the AAPL newsletter and as assistant to the editor of the Journal of the American Academy of Psychiatry and Law.1

Reference

1. AAPL names scholarship for Dike. Yale School of Medicine. News release. August 26, 2022. Accessed October 10, 2022. https://medicine.yale.edu/psychiatry/news-article/aapl-names-scholarship-for-dike/

Related Videos
MLK
Judaism
writing
Postpartum depression and major depressive disorder in pregnant and postpartum women are severely underdiagnosed and undertreated. How can we more effectively help this patient population?
© 2024 MJH Life Sciences

All rights reserved.